Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation.
Cytotherapy
; 13(6): 686-94, 2011 Jul.
Article
en En
| MEDLINE
| ID: mdl-21171824
ABSTRACT
BACKGROUND AIMS:
A previous study has demonstrated that mouse mesenchymal stromal cells (MSC) produce nitric oxide (NO), which suppresses signal transducer and activator of transcription (STAT) 5 phosphorylation and T-cell proliferation under neutral and T helper 1 cells (Th1) conditions. We aimed to determine the effects of MSC on T helper 17 cells (Th17) and regulatory T-cell (T-reg) differentiation.METHODS:
CD4 T cells obtained from mouse spleen were cultured in conditions for Th17 or Treg differentiation with or without mouse MSC. Th17 and Treg differentiation was assessed by flow cytometry using antibodies against interleukin (IL)-17 and forkhead box P3 (Foxp3), a master regulator of Treg cells.RESULTS:
MSC inhibited Th17 but not Treg differentiation. Under Th17 conditions, MSC did not produce NO, and inhibitors of indoleamine-2,3-dioxygenase (IDO) and prostaglandin E(2) (PGE2) both restored MSC suppression of differentiation, suggesting that MSC suppress Th17 differentiation at least in part through PGE2 and IDO.CONCLUSIONS:
Our results suggest that MSC regulate CD4 differentiation through different mechanisms depending on the culture conditions.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Células del Estroma
/
Linfocitos T Reguladores
/
Células Th17
/
Células Madre Mesenquimatosas
Límite:
Animals
Idioma:
En
Revista:
Cytotherapy
Asunto de la revista:
TERAPEUTICA
Año:
2011
Tipo del documento:
Article
País de afiliación:
Japón